Chen Bihua's Form 4 filing
MoonLake Immunotherapeutics (MLTX) · filed Mar 22, 2023
- Accession no.
- 0000929638-23-000895
- Filed
- Mar 22, 2023
- Trade date
- Mar 20-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $16.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chen BihuaCIK 0001599214 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | Class A Ordinary Shares | PPurchaseAcquired | +446,881 | $19.36 | +$8,651,616.16 | 3,296,881 | Indirect | |
| Mar 20, 2023 | Class A Ordinary Shares | PPurchaseAcquired | +63,700 | $20.42 | +$1,300,754 | 3,360,581 | Indirect | |
| Mar 20, 2023 | Class A Ordinary Shares | PPurchaseAcquired | +78,008 | $21.08 | +$1,644,408.64 | 3,438,589 | Indirect | |
| Mar 21, 2023 | Class A Ordinary Shares | PPurchaseAcquired | +238,511 | $21.70 | +$5,175,688.7 | 3,677,100 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.